Healthcare media attribution needs sound methods and clear decision rules.

Different measurement partners can report different answers because they observe different audiences, events, periods, and exposure paths. Governance helps resolve those differences, but it cannot repair incomplete data or turn an observational association into a causal result.

Define the question before choosing the method.

Start with the behavior the program is intended to influence and the decision the evidence will inform. Qualified reach, content engagement, a rep conversation, and prescribing activity answer different questions. An engagement measure can support an engagement objective without establishing prescribing impact.

Attribution assigns credit under a chosen rule. Incrementality asks what changed because of the activity compared with a credible counterfactual. Last-touch, time-decay, and multi-touch approaches do not become causal simply because the team agrees to use them. Where an outcome study is feasible, agree the comparison or holdout design, contamination risks, sample requirements, and analytical limitations with the measurement team.

Check what the data can observe.

Document exposure linkage, audience coverage, outcome completeness, baseline period, reporting lag, observation window, and permitted uses. Assess selection bias and potential confounders such as field activity, access changes, seasonality, or concurrent promotion. A small specialty audience may not support a precise effect estimate within the desired period.

Electronic health record data and medical or pharmacy claims data are distinct sources with different coverage and latency. Specify the actual source and method rather than treating them as interchangeable. A platform view-through report and a claims-linked study may answer different questions; reconcile their definitions before deciding which evidence applies.

Give each measure a decision role.

Agree which delivery measures support operational optimization and which study results can inform a broader investment decision. State the uncertainty, minimum evidence needed, and conditions under which no conclusion should be drawn. Avoid adding channel-level attributed outcomes together when audiences or attribution windows overlap.

Assign ownership before launch.

Name the analytics owner, the business decision-maker, and the escalation path. Ask prospective partners to demonstrate reporting access, study feasibility, and required permissions before contracting. If evidence is insufficient, record the gap and a proportionate learning plan. An agreed reporting hierarchy supports a decision; it does not override study validity.